“Colonoscopy” trends with Twitter reactions to study
This weekend, a study out of Oslo, Norway, published in the New England Journal of Medicine questioned the effectiveness of colonoscopy in preventing colorectal cancer, the second deadliest cancer in the United States. The study triggered a swell of media reports casting doubt on the procedure.
It also inspired a lot of tweeting and more than a few threads of analysis by experts, many of them taking issue with the simple conclusions made by news headlines or the study itself.
The Colorectal Cancer Alliance’s CEO, Michael Sapienza, made our position clear on Twitter.
Numerous physicians and researchers, including Houston-based gastroenterologist Manreet Kaur, took issue with the study’s methodology, including:
- Dr. Hamed Khalili, an associate professor at Harvard University, wonders if the study emphasized the wrong aspect of prevention.
- Dr. Meghan May, a professor of microbiology and infectious diseases at the University of New England, takes issue with some of the reporting on the study.
- Dr. Leo Nissola sets his sights on one report in particular.
- Anirban Maitra, pancreatic cancer researcher and GI pathologist, shared talk from around the water cooler.
- Jeremy Faust, an ER physician, was among the first to weigh in with a substantial piece, in which he encouraged readers to consider glimmers of hope before “flushing colonoscopies down the toilet.”
- Gastroenterologist and podcaster Dr. Kaveh Hoda produced a thread reinforcing Faust and adds that “populations in the countries of study are different than the US makeup.”
- Joining many others, Dr. John Damianos of Yale pointed to a critical editorial in the New England Journal of Medicine, which identifies some of the important issues in the study.
- Dr. Leonidas Platanias, director of Lurie Cancer Center of Northwestern University, calls for increased education.
- With all the media attention on this study, the public has questions. Dr. Sophie Balzora of the NYU Grossman School of Medicine has answers.
- Dr. Erin King-Mullins, a colorectal surgeon in Atlanta, is looking ahead to National Colorectal Cancer Awareness Month.
Read the Alliance’s statement on this study here.
Top resources
Alliance supports legislation for multi-cancer early detection
Learn how the Colorectal Cancer Alliance is advocating for the passage of the Nancy Gardner Sewell Multi-Cancer Early Detection Act (HR 2407), a bipartisan bill that ensures immediate Medicare coverage for life-saving cancer detection tests once approved by the FDA.
Alliance adds partners to expand 45+ Reasons campaign
The Alliance’s 45+ Reasons campaign is part of the Cycles of Impact initiative launched and supported by Independence Blue Cross in 2022 to address the urgent public health issue of colorectal cancer among the Black population.
Appeals Court decision protects access to no-cost preventive CRC screening
The U.S. Court of Appeals for the Fifth Circuit reversed a district court decision that had ruled provisions in the Affordable Care Act (ACA), which provide for no-cost preventive screening for colorectal cancer and other conditions, unconstitutional.